New precision medicine trial shows promise for treating rare brain tumors

FHS
July 13, 2023
1:44 pm

Papillary craniopharyngiomas (PCPs) are a rare type of brain tumor that cause substantial morbidity for patients.

Biocon’s insulin biosimilar rejected yet again by FDA after manufacturing deficiencies

The FDA has rejected Biocon Biologics’ biosimilar version of insulin aspart due to issues identified at its Malaysia facility after an Aug. 2022 inspection. The

October 10, 2023

Illumina names Agilent executive as new CEO

Illumina, the largest maker of DNA-sequencing technology and a storied name in the biotechnology industry, named Jacob Thaysen, a 10-year-veteran at life sciences-tools firm Agilent,

September 5, 2023

Updated: Exscientia CEO brought down by allegations of inappropriate employee relationships, in blow to AI pioneer

Over the last decade, Andrew Hopkins emerged as a public leader of the AI biotech field, jumping from a professor at a Scottish university to

February 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.